Recent Updates

Modified on: 
May 3, 2021

Transfusion Camp is a 5-day education program aimed at increasing knowledge of transfusion medicine and best practices by providing high-quality training to post-graduate medical trainees in various specialties related to transfusion.

Led by transfusion experts at the University of Toronto, Transfusion Camp is delivered to trainees from more than 12 different specialty training programs at more than 10 universities in Canada and abroad.

Transfusion
Modified on: 
May 3, 2021

Authors:  Jacob Pendergrast, B.A., B.Sc., MD, FRCPC; Donald Branch, B.Sc., MT (ASCP), PhD
Date of publication: July 2020

Transfusion
Modified on: 
May 2, 2021

The monthly OTDT digest has been developed to share highlights from our collaborative work with the organ and tissue donation and transplantation community. Subscribe by entering your email address in the box below. Please send contributions, comments and suggestions to otdt@blood.ca  

 

Organs and Tissues
Modified on: 
Apr 28, 2021

The content on this page is specific for 2020-2021 Transfusion Camp. Content for 2021-2022 will start being updated approximately one month ahead of the live event held in Toronto. See General Information Schedules and Locations document for live event dates.

Reminder:

Transfusion
Modified on: 
Apr 27, 2021

Forum Report and Recommendations

Advancing Living Donation Forum: Helping Kidney Transplant Candidates Identify Living DonorsAdvancing Living Donation 2020 Forum Report Cover Page

Organs and Tissues
Modified on: 
Apr 27, 2021

Welcome to the home of the NHLAAC Journal Club

Starting in November 2019, the NHLAAC committee conducted its first ABHI accredited Journal Club presentation with the goal of providing a venue for Canadian HLA professionals to continue their education, knowledge sharing, and receive ABHI CE credits.

Organs and Tissues
Modified on: 
Apr 27, 2021
National COVID-19 Impact Data Dashboard 
Organs and Tissues
Modified on: 
Apr 22, 2021

All blood transfused in Canada is collected from volunteer donors. To ensure the safety of blood components, donors are carefully screened. In addition, the donated blood is tested to identify blood group, blood group antibodies and transfusion-transmissible pathogens. Donor eligibility criteria and testing also benefit the donors by reducing potential blood donation-related health risks.

This chapter describes the donor selection process, the testing done on donated blood, and the pathogen inactivation processes that can further reduce risk of transfusion-transmitted diseases. This chapter is complemented by Chapter 7, Fractionated Blood products and Associated Pathogen Safety, and Chapter 8, Pre-transfusion Testing, of this Guide.

Transfusion
Modified on: 
Apr 22, 2021

Modified or specialty blood components may be useful in specific clinical settings to reduce the risk of transfusion-related harm. This chapter describes the preparation of irradiated, washed, and CMV seronegative cellular blood components (red blood cells and platelets) and the clinical setting in which they are of greatest benefit.

Transfusion
Modified on: 
Apr 21, 2021

This chapter focuses on preoperative autologous donation (PAD). PAD refers to the donation of blood by a patient for their own future use; generally, this is for a scheduled elective surgery. The top three procedures associated with a request for a PAD are total hip replacement, total knee replacement and hysterectomy.1

There are other types of autologous blood use (e.g., acute normovolemic hemodilution and intraoperative and postoperative blood salvage) which are not discussed in this chapter.

Autologous and directed donations should be confined to circumstances of rare blood types2 or plasma protein deficiencies in which allogeneic blood components may not meet patient needs. In all other cases, allogeneic blood transfusions are a safe option. See Chapter 13 of this Guide for more information on directed donations for neonatal and pediatric transfusion.

Transfusion

Pages